Clinical Trial Update: Sustained Treatment-free Remission in BCR-ABL+ Chronic Myeloid Leukemia [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update reports sustained treatment-free remission in patients with BCR-ABL+ chronic myeloid leukemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Myeloid Leukemia

Snippet

Sponsor: Gruppo Italiano Malattie EMatologiche dell'Adulto | Conditions: Chronyc Myeloid Leukemia | Phase 4 | Status: UNKNOWN